0
Signin
countryflagCA

888-969-2592

RY 144.17 0.4529% TD 77.39 0.0517% SHOP 78.87 -1.3878% CNR 171.64 0.5625% ENB 50.09 -0.4769% CP 110.62 0.6277% BMO 128.85 -0.548% TRI 233.58 1.1563% CNQ 103.29 -0.174% BN 60.87 -0.2295% ATD 75.6 -1.447% CSU 3697.0 1.1582% BNS 65.76 -0.3485% CM 66.6 -0.5525% SU 54.21 1.1569% TRP 53.15 0.3398% NGT 58.54 -0.3405% WCN 226.5 0.4123% MFC 35.905 0.9986% BCE 46.75 -0.5954%

VentriPoint Diagnostics Ltd

Healthcare CA VPT

0.22CAD
-0.005(2.22%)

Last update at 2024-05-16T19:30:00Z

Day Range

0.210.23
LowHigh

52 Week Range

0.120.36
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.87280M -3.88103M -1.85068M -3.32263M -2.08401M
Minority interest - - - - -
Net income -4.87280M -3.88103M -1.85068M -3.32263M -2.08401M
Selling general administrative 3.87M 3.22M 1.60M 2.23M 2.39M
Selling and marketing expenses - - - - -
Gross profit 0.06M 0.00000M 0.03M 0.04M 0.03M
Reconciled depreciation 0.05M 0.05M 0.05M 0.06M 0.03M
Ebit - - -1.90985M -3.28277M -3.82323M
Ebitda -4.79373M -3.81926M -1.56643M -3.16848M -2.05573M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -4.91073M -3.71542M -1.88910M -3.28277M -3.82323M
Other operating expenses - - - - -
Interest expense 0.03M 0.01M 0.23M 0.09M 0.00000M
Tax provision - - - - -
Interest income 0.03M 0.05M 0.01M - -
Net interest income -0.00996M 0.03M -0.21974M -0.09892M -0.00461M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.07M 0.00000M 0.04M 0.08M 0.06M
Total operating expenses 4.98M 3.72M 1.93M 3.36M 3.88M
Cost of revenue 0.01M 0.00000M 0.00975M 0.04M 0.03M
Total other income expense net 0.05M -0.19758M 0.26M 0.06M 1.74M
Discontinued operations - - - - -
Net income from continuing ops -4.87280M -3.88103M -1.85068M -3.32263M -2.08401M
Net income applicable to common shares - - -1.85068M -3.32263M -2.08401M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 5.98M 9.54M 0.80M 0.31M 0.47M
Intangible assets - - - - 0.04M
Earning assets - - - - -
Other current assets - - - - -
Total liab 1.42M 1.21M 3.15M 2.78M 1.44M
Total stockholder equity 4.55M 8.33M -2.34863M -2.46944M -0.97326M
Deferred long term liab - - - - -
Other current liab - - 0.00050M 0.01M 0.14M
Common stock - - 31.01M 29.48M 28.62M
Capital stock 42.68M 42.21M 31.01M 29.48M 28.62M
Retained earnings -48.62101M -43.74821M -39.86718M -37.94725M -34.62002M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 5.19M 9.27M 0.53M 0.01M 0.07M
Cash and equivalents - - - - -
Total current liabilities 1.06M 1.09M 1.82M 1.92M 1.44M
Current deferred revenue - - - - -
Net debt - - 0.77M 1.00M -
Short term debt - - - - -
Short long term debt 0.05M - - 0.22M -
Short long term debt total - - - - -
Other stockholder equity - - 0.11M - -
Property plant equipment - - 0.09M 0.14M 0.05M
Total current assets 5.66M 9.50M 0.71M 0.18M 0.38M
Long term investments - - - - -
Net tangible assets - - -2.34863M -2.46944M -1.01060M
Short term investments - - - - -
Net receivables 0.04M - 0.17M 0.07M 0.08M
Long term debt 0.09M 0.13M 1.29M 0.79M -
Inventory - - 0.00000M 0.03M 0.07M
Accounts payable 0.84M 0.99M 1.01M 1.20M 0.73M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.14M 0.09M
Deferred long term asset charges - - - - -
Non current assets total 0.31M 0.04M 0.09M 0.14M 0.09M
Capital lease obligations 0.32M 0.03M 0.08M 0.11M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M -0.00426M -0.00376M -0.01710M -0.02737M
Change to liabilities - - 0.15M 0.33M 0.15M
Total cashflows from investing activities - - -0.00376M -0.01710M -0.02737M
Net borrowings - - 1.16M 1.68M 1.68M
Total cash from financing activities 0.09M 11.89M 1.62M 2.34M 1.84M
Change to operating activities - - 0.04M 0.10M -0.05098M
Net income -4.87280M -3.88103M -1.85068M -3.32263M -2.08401M
Change in cash -4.08319M 8.74M 0.51M -0.05280M -1.29236M
Begin period cash flow 9.27M 0.53M 0.01M 0.07M 1.36M
End period cash flow 5.19M 9.27M 0.53M 0.01M 0.07M
Total cash from operating activities -4.13674M -3.14676M -1.10035M -2.38129M -3.04899M
Issuance of capital stock 0.00000M 8.06M - 0.70M 1.86M
Depreciation 0.05M 0.05M 0.05M 0.06M 0.03M
Other cashflows from investing activities - - - - -
Dividends paid - - - 0.00000M 0.00000M
Change to inventory - 0.00000M 0.03M 0.04M -0.01841M
Change to account receivables - - -0.09769M 0.01M 0.02M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - -0.06675M -0.04369M -0.02827M
Change to netincome - - 0.57M 0.40M -1.10325M
Capital expenditures 0.00000M 0.00426M 0.00376M 0.02M 0.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.33106M -0.46259M 0.12M 0.48M 0.10M
Stock based compensation 0.80M 0.90M 0.39M 0.21M -
Other non cash items 0.22M -0.02646M 0.20M 0.28M 0.21M
Free cash flow -4.13674M -3.15102M -1.10412M -2.39839M -3.07636M

Fundamentals

  • Previous Close 0.23
  • Market Cap49.40M
  • Volume381004
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.79568M
  • Revenue TTM0.04M
  • Revenue Per Share TTM-
  • Gross Profit TTM -0.00627M
  • Diluted EPS TTM-0.03

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VPT
VentriPoint Diagnostics Ltd		 -0.005 2.22% 0.22 - - 1376.49 34.01 1193.16 -9.1712
PINK
Perimeter Medical Imaging AI Inc		 -0.01 1.75% 0.56 - - 117.72 2.89 122.12 -4.2252
TLT
Theralase Technologies Inc.		 -0.005 3.03% 0.16 - - 35.41 23.10 36.69 -9.1528
ASG
Aurora Spine Corp		 0.01 3.77% 0.28 - - 1.83 5.11 2.14 -31.4665
NGMD
NuGen Medical Devices Inc		 -0.005 4.76% 0.10 - - 107.75 9.71 118.72 -4.5025

Reports Covered

Stock Research & News

View All

Profile

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

VentriPoint Diagnostics Ltd

18 Hook Avenue, Toronto, ON, Canada, M6P 1T4

Key Executives

Name Title Year Born
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. Exec. Chairman & Interim CEO 1952
Mr. Victor Hugo C.M.A., CPA Chief Financial Officer 1970
Dr. Alvira Macanovic Ph.D. VP of Operations, Regulatory Affairs & Quality Assurance NA
Mr. Hirotaka Katagiri CTO & Bus. Devel. Division Director NA
Ms. Jessica Naman Director of Marketing NA
Mr. Desmond Hirson Consultant NA
Mr. Jim Graba Application Specialist & Chief Trainer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).